At a glance
ClinicalIndex Comparison RecordN/ACompleted· 657 enrolled
Drug / intervention
Lutonix Drug Coated Balloondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multicenter, LEVANT 2 Continuation Registry of the Moxy™ Drug Coated Balloon for Treatment of Femoropopliteal Arteries
In Brief
A clinical study evaluating Lutonix Drug Coated Balloon for Peripheral Artery Disease. Completed, enrolled 657 participants across 64 sites in 5 countries.
Detailed Summary
The purpose of the study is to collect additional safety and efficacy information on the Lutonix (formerly Moxy) Drug Coated Balloon for treatment of stenosis or occlusion of the femoral and popliteal arteries.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Artery Disease
CountriesAustria, Belgium, Germany, Switzerland, United States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2012
First PostedJun 2012
Primary CompletionSep 2018
Study CompletionDec 2018
TodayJul 2026
First PostedJun 26, 2012
Enrollment StartJun 1, 2012
Primary CompletionSep 1, 2018
Study CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 14.0 years ago
Interventions
Lutonix Drug Coated Balloondevice
balloon angioplasty with a drug coated balloon